The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence on the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
Feedback is being sought from developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.
According to the two organisations, the survey forms part of the programme's Phase 1 evaluation. It is intended to assess how the resources have been received and used across the sector, and in particular whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
Scope of the resources
The materials were created to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools. Findings from the survey will be used to determine whether the Phase 1 outputs achieved their intended objectives and to inform the future direction of Phase 2 of the DMHT programme.
Participation encouraged at all levels of engagement
MHRA and NICE said stakeholders are encouraged to take part whether they have engaged with the existing resources extensively, minimally or not at all. The feedback, the organisations said, will help identify strengths, highlight areas for improvement and shape future work aimed at improving the safety and effectiveness of digital mental health technologies.